Brainomix

AI imaging solutions that support clinicians to make faster, more confident treatment decisions from any imaging modality in the acute stroke pathway.

Company Overview

Since launching as a University of Oxford spin-out in 2010, Brainomix have developed award-winning AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. 

Brainomix drives improvement in patient outcomes by enhancing doctors’ decisions and working with pharmaceutical companies to translate treatments into clinical practice.

Brainomix 360 (called e-Stroke outside of the U.S.) is a comprehensive AI imaging suite of solutions that supports clinicians to make faster, more confident treatment decisions from any imaging modality in the acute stroke pathway.

Brainomix horizontal logo

Modalities

MRI-icon-2-150x150

Subspecialities

Neuro-icon-150x150

Applications available

Brainomix-easpects-logo

e-ASPECTS

Non-contrast brain CT analysis that automatically generates an ASPECTS score.

CE

FDA

CT

Neuro

e-CTA-logo-1

e-CTA

Decision support tool that helps the assessment of collaterals on CT Angiography.

CE

FDA

CT

Neuro

e-CTP-logo-1

e-CTP

CT perfusion analysis tool that helps identify and estimate ischemic core and tissue-at-risk.

CE

FDA

CT

Neuro

To find out more about Brainomix’s solutions, or the 100+ other applications on the Blackford Platform, book a discovery call with our team.

review image 1

Book a meeting

We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.

Book a Meeting